LifeMD Inc

LifeMD Inc

LFMD · NASDAQ · Healthcare / Health Information Services

2.20USD+0.55 (+32.93%)

Price History

Full chart

Market Stats

Previous Close1.66
Open1.87
Day Range1.85 – 2.34
52-Week Range2.56 – 7.32
Volume6.14M
Market Cap143.16M
P/E (TTM)0.00
Forward P/E12.85
EPS-0.53
Dividend Yield0.00%
Beta2.04
50-Day Avg3.43
200-Day Avg3.81

About

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Justin Schreiber
  • Employees347
  • Headquarters236 Fifth Avenue, New York, NY, United States, 10001, USA
  • Websitehttps://lifemd.com

Leadership

  • Mr. Justin SchreiberChairman & CEO · b. 1983
  • Ms. Shayna Webb DrayChief Operating Officer · b. 1987
  • Mr. Stefan GalluppiChief Innovation Officer · b. 1987
  • Mr. Atul KavthekarChief Financial Officer
  • Ms. Maria E. Stan CPAChief Accounting Officer & Controller · b. 1975
  • Mr. Umesh SripadChief Technology Officer
  • Mr. Eric H. YeciesChief Legal Officer, General Counsel & Corporate Secretary · b. 1978
  • Mr. Shane BiffarChief Compliance Officer & Deputy General Counsel · b. 1983
  • Mr. Chris PisanoChief Marketing Officer · b. 1975
  • Mr. James PorteSVP of Care Center Operations

Financials

Income Statement

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue743.83K673.78K808.36K714.16K1.22M5.24M5.05M8.32M12.47M37.29M92.88M119.03M152.55M212.45M194.06M
Growth (%)--9.42%+19.97%-11.65%+70.67%+329.79%-3.51%+64.68%+49.79%+199.10%+149.04%+28.16%+28.15%+39.27%-8.66%
Cost of Revenue241.26K125.62K181.30K172.85K247.77K1.95M1.48M1.97M2.53M8.91M18.00M18.67M18.90M24.07M39.29M
Gross Profit502.56K548.16K627.06K541.31K971.09K3.29M3.57M6.36M9.94M28.39M74.88M100.37M133.65M188.39M154.76M
Gross Margin67.56%81.36%77.57%75.80%79.67%62.85%70.65%76.35%79.75%76.12%80.62%84.32%87.61%88.67%79.75%
Operating Expense1.08M1.09M1.17M1.07M1.23M4.47M4.64M8.41M12.83M86.21M129.18M143.81M148.14M204.53M162.43M
Operating Income-576.37K-540.02K-546.41K-530.88K-262.22K-1.17M-1.07M-2.06M-2.89M-57.82M-54.30M-43.45M-14.49M-16.14M-7.67M
Operating Margin-77.49%-80.15%-67.59%-74.34%-21.51%-22.42%-21.12%-24.70%-23.18%-155.04%-58.47%-36.50%-9.50%-7.60%-3.95%
EBITDA-442.18K-402.50K-225.10K-416.02K-91.21K-1.17M-1.07M-1.86M-2.55M-57.42M-57.94M-38.60M-8.21M-6.65M-1.52M
EBITDA Margin-59.45%-59.74%-27.85%-58.25%-7.48%-22.42%-21.12%-22.35%-20.48%-153.97%-62.39%-32.43%-5.38%-3.13%-0.78%
Net Income-502.93K-445.65K-268.26K-460.49K-61.99K-1.11M-1.21M-1.24M-3.14M-60.52M-60.90M-45.54M-20.60M-18.88M-7.11M
Net Income Margin-67.61%-66.14%-33.19%-64.48%-5.09%-21.14%-23.86%-14.91%-25.16%-162.29%-65.57%-38.25%-13.50%-8.89%-3.66%
R&D----23.93K--120.54K222.88K446.75K948.16K2.97M6.06M9.51M7.35M
R&D as % of Total Revenue----1.96%--1.45%1.79%1.20%1.02%2.50%3.97%4.48%3.79%
Interest Expense21.26K3.37K3.38K4.68K37.48K48.61K100.52K354.39K761.15K1.67M3.02M1.28M2.60M2.18M1.36M
Interest Expense % of Total Revenue2.86%0.50%0.42%0.66%3.07%0.93%1.99%4.26%6.10%4.47%3.25%1.07%1.70%1.03%0.70%

Balance Sheet

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets343.33K369.69K551.45K175.22K448.47K789.82K1.26M2.62M3.45M13.40M49.92M25.67M58.48M72.46M70.41M
Total Liabilities626.31K234.70K355.96K314.72K267.48K1.15M640.97K1.80M4.58M14.22M24.10M32.97M52.91M76.51M47.25M
Total Equity-282.98K135.00K195.49K-139.50K100.08K-355.17K881.92K897.70K-988.18K1.35M26.85M-6.83M3.51M-5.49M23.16M
Cash33.50K98.93K155.06K75.50K232.98K182.56K141.38K180.09K1.11M9.18M41.33M3.96M33.15M35.00M36.79M
Total Debt262.17K-40.20K27.20K100.00K206.37K167.48K247.42K844.71K1.06M1.85M4.13M18.93M25.10M6.32M
Net Debt228.67K-98.93K-114.86K-48.30K-132.98K23.80K26.10K67.32K-261.91K-8.11M-39.48M168.52K-14.21M-9.90M-30.46M

Cash Flow

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-17.69K-229.73K-259.07K33.44K-295.12K-407.91K-817.22K-905.52K251.41K-12.13M-33.09M-22.94M8.82M17.51M8.28M
Investing Cash Flow----127.26K219.89K63.38K141.44K-100.00K-798.14K-3.40M-13.91M-8.73M-11.54M6.91M
Financing Cash Flow51.19K295.15K315.20K-113.00K325.35K357.49K776.03K802.79K775.12K21.00M68.64M-528.20K29.10M-4.12M-13.41M
Capital Expenditure0000000100.00K247.37K398.14K3.40M12.89M8.73M11.54M9.52M
Free Cash Flow-17.69K-229.73K-259.07K33.44K-295.12K-407.91K-817.22K-1.01M251.41K-12.53M-36.49M-35.83M86.95K5.98M-1.24M
Dividends Paid----10.80K330.00K878.86K871.48K871.48K1.29M871.48K3.11M3.11M3.11M3.11M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%111.04%100.00%103.28%110.28%156.22%0.99%34.13%-14.96%
Dividend Paid to FCF-----3.66%-80.90%-107.54%-86.67%346.64%-10.29%-2.39%-8.67%3572.54%51.97%-250.82%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Nov 14, 2019Mar 30, 2020May 19, 2020Aug 14, 2020Nov 16, 2020Mar 29, 2021May 13, 2021Aug 12, 2021Nov 10, 2021Mar 7, 2022May 13, 2022Aug 11, 2022Nov 10, 2022Mar 22, 2023May 12, 2023Aug 9, 2023Nov 7, 2023Mar 11, 2024May 8, 2024Aug 7, 2024Nov 7, 2024Mar 10, 2025May 6, 2025Aug 5, 2025Nov 17, 2025Mar 9, 2026May 8, 2026Aug 5, 2026Nov 16, 2026
EPS Estimate---------------------------------------1.03-0.24-0.44-0.45-0.49-0.39-0.36-0.23-0.12-0.18-0.160.030.03-0.14-0.010.040.070.140.140.180.050.09-0.12-0.20-0.14
EPS Actual-0.010.000.00-0.10-0.01-0.02-0.04-0.01-0.01-0.00-0.02-0.01-0.02-0.01-0.02-0.020.00-0.000.00-0.01-0.01-0.03-0.03-0.09-0.140.08-0.08-0.030.07-0.07-0.06-0.09-0.07-0.09-0.09-0.07-0.22-2.54-1.03-2.56-0.48-0.51-0.36-0.29-0.46-0.22-0.03-0.40-0.150.050.08-0.120.010.060.090.210.03-0.01-0.080.06-0.15-0.16-
Surprise--------------------------------------0.00%-966.67%-9.09%-13.33%26.53%25.64%-27.78%4.35%75.00%-122.22%6.25%66.67%166.67%14.29%200.00%50.00%28.57%50.00%-78.57%-105.56%-260.00%-33.33%-29.91%20.00%-
Timing-----------------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hours-

Key Statistics & Ratios

Market Cap143.16M
Enterprise Value128.13M
Trailing P/E0.00
Forward P/E12.85
Price / Sales0.75
Price / Book18.48
EPS-0.53
Book Value0.167
Revenue (TTM)191.59M
Gross Profit (TTM)167.64M
EBITDA-18.96M
Profit Margin0.11%
Operating Margin-15.08%
Return on Equity-515.90%
Return on Assets-18.92%
Shares Outstanding48.20M
Shares Float39.66M
Beta2.04
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 8 analystsTarget 8.13
  • Strong Buy
    6
  • Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
45.01%
Insiders
15.80%
Retail / Other
39.19%

Top Institutional Holders

  • BlackRock Inc
    2.81M5.83%
  • Federated Hermes Inc
    2.75M5.70%
  • Vanguard Capital Management, LLC
    1.66M3.45%
  • Royce & Associates, LP
    1.20M2.49%
  • Renaissance Technologies Corp
    1.12M2.32%
  • State Street Corp
    1.08M2.23%
  • Geode Capital Management, LLC
    1.02M2.12%
  • Prescott Group Capital Management LLC
    895.42K1.86%
  • BRC Group Holdings Inc
    871.58K1.81%
  • Susquehanna International Group, LLP
    465.19K0.97%
  • The Goldman Sachs Group Inc
    459.80K0.95%
  • Millennium Management LLC
    401.62K0.83%
  • Jane Street Group LLC
    366.67K0.76%

Top Fund Holders

  • Federated Hermes MDT Small Cap Core IS
    1.43M2.96%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.22M2.54%
  • iShares Russell 2000 ETF
    1.03M2.13%
  • Bridge Builder Small/Mid Cap Growth
    851.51K1.77%
  • Federated Hermes MDT Small Cap Growth IS
    595.33K1.24%
  • Stt Strt®SPDR®S&PKenshoNwEcosComposETF
    525.96K1.09%
  • Fidelity Small Cap Index
    435.81K0.90%

Stock Splits

  • Oct 14, 20201:5